4-Anilino- N -phenylethylpiperidine (4-ANPP): the potential caution flag for illicit fentanyl
- 6 January 2026
- journal article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 50 (3)
Abstract
The ability to distinguish illicit fentanyl use is becoming increasingly critical in toxicological investigations. 4-Anilino-N-phenylethylpiperidine (4-ANPP), also known as despropionylfentanyl, is both a precursor in illicit fentanyl production and a minor metabolite frequently detected alongside fentanyl in forensic toxicology. Its presence may assist in distinguishing medical and illicit fentanyl sources. This study evaluated 4-ANPP concentrations and 4-ANPP: fentanyl (4-ANPP to fentanyl) ratios in clinical (presumed medicinal) and postmortem (forensic) submissions to ascertain trends that may aid in source attribution and toxicological interpretation. Blood and serum/plasma (s/p) samples were analyzed via liquid-liquid extraction followed by liquid chromatography tandem mass spectrometry (LC–MS/MS) throughout 2023. A total of 32 723 forensic and 1015 clinical cases positive for fentanyl were included in the analysis. Most clinical 4-ANPP concentrations (69%) were below 0.50 ng/mL, compared to 20% of forensic cases. Forensic blood samples with reportable 4-ANPP concentrations (n = 29 701) had a median of 2.1 ng/mL (mean ± SD: 6.5 ± 42 ng/mL, range: 0.20–4100 ng/mL). In clinical serum/plasma samples with reportable 4-ANPP (n = 451), the median was 0.96 ng/mL (mean ± SD: 3.9 ± 17 ng/mL, range: 0.20–306 ng/mL). In cases with reportable 4-ANPP concentrations, the median 4-ANPP: fentanyl ratio was 0.141 (mean ± SD: 0.22 ± 0.95; range: 0.000078–140) for forensic, while the clinical median was 0.105 (mean ± SD: 0.44 ± 3.0; range: 0.005–60). Notably, 91% of forensic cases had reportable 4-ANPP concentrations (≥0.20 ng/mL) compared to 44% of clinical cases, excluding more than half of the clinical cases from ratio calculations. Although overlapping 4-ANPP: fentanyl ratios limit its utility as a clear indicator of illicit fentanyl use, elevated 4-ANPP concentrations are more strongly associated with non-pharmaceutical sources and may serve as valuable support in forensic interpretation.Keywords
This publication has 6 references indexed in Scilit:
- The rise and rise of fentanyl in postmortem caseworkJournal of Forensic Sciences, 2023
- Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology CaseworkJournal of Analytical Toxicology, 2022
- Phenethyl-4-ANPP: A Marginally Active Byproduct Suggesting a Switch in Illicit Fentanyl Synthesis RoutesJournal of Analytical Toxicology, 2021
- Analysis of 17 fentanyls in plasma and blood by UPLC-MS/MS with interpretation of findings in surgical and postmortem caseworkClinical Mass Spectrometry, 2020
- Postmortem Redistribution of Fentanyl in BloodAmerican Journal of Clinical Pathology, 2010
- Duragesic(R) Transdermal Patch: Postmortem Tissue Distribution of Fentanyl in 25 CasesJournal of Analytical Toxicology, 2000